483 Merck Sharp & Dohme Oct 2017

483 Merck Sharp & Dohme Oct 2017

Michael Serrano FDA, Shirley Wen FDA, Nina Yang FDA, Bei Yu FDA$119.00 - Available Now

FDA investigators audited the Merck Sharp & Dohme - Rahway, NJ, United States facility and issued inspectional observations (via FDA 483) on 30 Oct 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 30 Oct 2017
  • Location: Rahway, United States
  • FEI: 2211017
Add To Cart